Company Profiles

driven by the PitchBook Platform

Adenovir Pharma

Adenovir Pharma
2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$677k LATEST DEAL AMOUNT
$6.99M TOTAL AMOUNT RAISED
Description

Developer of pharmaceutical products for the treatment of a viral eye infection. The company is focused on development of a topical antiviral pharmaceutical product for treatment and potential use for prevention of adenoviral conjunctivitis, epidemic keratoconjunctivitis (EKC).

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
Kullagatan 8
252 20 Helsingborg
Sweden
+46 (0)42 38 74 28
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adenovir Pharma’s full profile, request a free trial.

Adenovir Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 27-Apr-2016 $677k $6.99M Completed Generating Revenue
6. Grant 29-Jun-2015 000.00 00.000 Completed Generating Revenue
5. Early Stage VC 22-Jan-2013 00.000 00.000 Completed Startup
4. Early Stage VC 15-Jul-2012 00.000 00.000 Completed Startup
3. Early Stage VC 12-Apr-2011 00.000 00.00 Completed Startup
2. Early Stage VC 15-Jun-2010 $778k $778k Completed Startup
1. Accelerator/Incubator 01-Jan-2008 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Adenovir Pharma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Augmenta Venture Capital Minority 000 0000 000000 0
BWG PE-Backed Company Minority 000 0000 000000 0
Länsförsäkringar Limited Partner Minority 000 0000 000000 0
Partners for Development Investments in Life Sciences Accelerator/Incubator Minority 000 0000 000000 0
Sparbankstiftelsen Skånes Riskkapitalstiftels Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Adenovir Pharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Björn Dellgren Chief Executive Officer & Project Leader

Adenovir Pharma Board Members (9)

Name Representing Role Since Contact
Info
Björn Lundgren Ph.D Self Board Member 000 0000
Göran Wadell MD Self Board Member 000 0000
Karin Wingstrand Self Board Member 000 0000
Kjell Oberg Ph.D Self Deputy Board Member 000 0000
Lennart Bruce Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »